First Trust Nasdaq Pharmaceuticals ETF
FTXH
FTXH
22 hedge funds and large institutions have $8.87M invested in First Trust Nasdaq Pharmaceuticals ETF in 2023 Q4 according to their latest regulatory filings, with 8 funds opening new positions, 4 increasing their positions, 6 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less ownership
Funds ownership: →
less capital invested
Capital invested by funds: $ → $
33% less repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 6
Holders
22
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$711K | |
| 2 | +$615K | |
| 3 | +$518K | |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$212K |
| 5 |
OMC
Old Mission Capital
Chicago,
Illinois
|
+$210K |
Top Sellers
| 1 | -$2.98M | |
| 2 | -$703K | |
| 3 | -$206K | |
| 4 |
NA
NewEdge Advisors
New Orleans,
Louisiana
|
-$186K |
| 5 |
Osaic Holdings
Scottsdale,
Arizona
|
-$53.5K |